Core Viewpoint - Yongtai Bio-B (06978) has announced a conditional agreement to issue new convertible bonds worth RMB 270 million and notes worth RMB 30 million, aimed at repaying existing convertible bonds due on February 20, 2026 [1] Group 1: Convertible Bonds and Notes - The new convertible bonds will have an initial conversion price of HKD 2.92 per share, equivalent to RMB 2.62 [1] - Upon full exercise of the conversion rights attached to the new convertible bonds, a maximum of 103 million shares will be issued, representing approximately 16.66% of the existing issued shares and about 14.28% of the enlarged issued shares after the conversion [1] Group 2: Use of Proceeds - The proceeds from the subscription will be exclusively used for the full and final repayment of the 2023 convertible bonds [1] - The issuance of the new convertible bonds and notes will be secured by collateral as per the relevant documentation [1] Group 3: Conditions and Agreements - The investors are required to sign a repayment deed in favor of the company, confirming the full and final repayment of the 2023 convertible bonds upon receipt of the new convertible bonds and notes [1]
永泰生物-B拟发行2.7亿元的新可换股债券及3000万元的票据